Search Orphan Drug Designations and Approvals
-
Generic Name: | margetuximab |
---|---|
Date Designated: | 06/03/2020 |
Orphan Designation: | Treatment of gastric and gastroesophageal junction cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
MacroGenics, Inc. 9704 Medical Center Drive Rockville, Maryland 20850 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-